Design and Optimization of the Single-Stage Continuous Mixed Suspension–Mixed Product Removal Crystallization of 2‑Chloro‑N‑(4-methylphenyl)propenamide
A continuously operated single-stage mixed suspension–mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro-N-(4-methylphenyl)propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key...
Saved in:
Published in | ACS omega Vol. 7; no. 16; pp. 13676 - 13686 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
26.04.2022
|
Online Access | Get full text |
ISSN | 2470-1343 2470-1343 |
DOI | 10.1021/acsomega.1c07228 |
Cover
Abstract | A continuously operated single-stage mixed suspension–mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro-N-(4-methylphenyl)propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key to developing a methodology linking the synthesis and purification unit operations of CNMP and gave further insight in the development of continuous process trains for active pharmaceutical ingredient materials. By monitoring how parameters such as cooling and agitation rates influence particle size and the yield, two batch start-up strategies were compared. The second part of the study focused on developing and optimizing the continuous cooling crystallization of CNMP in the MSMPR crystallizer in relation to the yield by determining the effects of varying the residence time and the agitation rates. During the MSMPR operation, the plot of the focused beam reflectance measurement total counts versus time oscillates and reaches an unusual state of control. Despite the oscillations, the dissolved concentration was constant. The yield and production rate from the system were constant after two residence times, as supported by FTIR data. The overall productivity was higher at shorter residence times (τ), and a productivity of 69.51 g/h for τ = 20 min was achieved for the isolation of CNMP. |
---|---|
AbstractList | A continuously operated single-stage mixed suspension-mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro-
-(4-methylphenyl)propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key to developing a methodology linking the synthesis and purification unit operations of CNMP and gave further insight in the development of continuous process trains for active pharmaceutical ingredient materials. By monitoring how parameters such as cooling and agitation rates influence particle size and the yield, two batch start-up strategies were compared. The second part of the study focused on developing and optimizing the continuous cooling crystallization of CNMP in the MSMPR crystallizer in relation to the yield by determining the effects of varying the residence time and the agitation rates. During the MSMPR operation, the plot of the focused beam reflectance measurement total counts versus time oscillates and reaches an unusual state of control. Despite the oscillations, the dissolved concentration was constant. The yield and production rate from the system were constant after two residence times, as supported by FTIR data. The overall productivity was higher at shorter residence times (τ), and a productivity of 69.51 g/h for τ = 20 min was achieved for the isolation of CNMP. A continuously operated single-stage mixed suspension–mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro- N -(4-methylphenyl)propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key to developing a methodology linking the synthesis and purification unit operations of CNMP and gave further insight in the development of continuous process trains for active pharmaceutical ingredient materials. By monitoring how parameters such as cooling and agitation rates influence particle size and the yield, two batch start-up strategies were compared. The second part of the study focused on developing and optimizing the continuous cooling crystallization of CNMP in the MSMPR crystallizer in relation to the yield by determining the effects of varying the residence time and the agitation rates. During the MSMPR operation, the plot of the focused beam reflectance measurement total counts versus time oscillates and reaches an unusual state of control. Despite the oscillations, the dissolved concentration was constant. The yield and production rate from the system were constant after two residence times, as supported by FTIR data. The overall productivity was higher at shorter residence times (τ), and a productivity of 69.51 g/h for τ = 20 min was achieved for the isolation of CNMP. A continuously operated single-stage mixed suspension-mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro-N-(4-methylphenyl)propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key to developing a methodology linking the synthesis and purification unit operations of CNMP and gave further insight in the development of continuous process trains for active pharmaceutical ingredient materials. By monitoring how parameters such as cooling and agitation rates influence particle size and the yield, two batch start-up strategies were compared. The second part of the study focused on developing and optimizing the continuous cooling crystallization of CNMP in the MSMPR crystallizer in relation to the yield by determining the effects of varying the residence time and the agitation rates. During the MSMPR operation, the plot of the focused beam reflectance measurement total counts versus time oscillates and reaches an unusual state of control. Despite the oscillations, the dissolved concentration was constant. The yield and production rate from the system were constant after two residence times, as supported by FTIR data. The overall productivity was higher at shorter residence times (τ), and a productivity of 69.51 g/h for τ = 20 min was achieved for the isolation of CNMP.A continuously operated single-stage mixed suspension-mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro-N-(4-methylphenyl)propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key to developing a methodology linking the synthesis and purification unit operations of CNMP and gave further insight in the development of continuous process trains for active pharmaceutical ingredient materials. By monitoring how parameters such as cooling and agitation rates influence particle size and the yield, two batch start-up strategies were compared. The second part of the study focused on developing and optimizing the continuous cooling crystallization of CNMP in the MSMPR crystallizer in relation to the yield by determining the effects of varying the residence time and the agitation rates. During the MSMPR operation, the plot of the focused beam reflectance measurement total counts versus time oscillates and reaches an unusual state of control. Despite the oscillations, the dissolved concentration was constant. The yield and production rate from the system were constant after two residence times, as supported by FTIR data. The overall productivity was higher at shorter residence times (τ), and a productivity of 69.51 g/h for τ = 20 min was achieved for the isolation of CNMP. A continuously operated single-stage mixed suspension–mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro-N-(4-methylphenyl)propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key to developing a methodology linking the synthesis and purification unit operations of CNMP and gave further insight in the development of continuous process trains for active pharmaceutical ingredient materials. By monitoring how parameters such as cooling and agitation rates influence particle size and the yield, two batch start-up strategies were compared. The second part of the study focused on developing and optimizing the continuous cooling crystallization of CNMP in the MSMPR crystallizer in relation to the yield by determining the effects of varying the residence time and the agitation rates. During the MSMPR operation, the plot of the focused beam reflectance measurement total counts versus time oscillates and reaches an unusual state of control. Despite the oscillations, the dissolved concentration was constant. The yield and production rate from the system were constant after two residence times, as supported by FTIR data. The overall productivity was higher at shorter residence times (τ), and a productivity of 69.51 g/h for τ = 20 min was achieved for the isolation of CNMP. |
Author | Jones, Roderick C Donnellan, Philip Pascual, Gladys Kate Glennon, Brian Wood, Barbara |
AuthorAffiliation | APC Ltd Synthesis and Solid State Pharmaceutical Centre (SSPC), School of Chemical and Bioprocess Engineering |
AuthorAffiliation_xml | – name: APC Ltd – name: Synthesis and Solid State Pharmaceutical Centre (SSPC), School of Chemical and Bioprocess Engineering |
Author_xml | – sequence: 1 givenname: Gladys Kate surname: Pascual fullname: Pascual, Gladys Kate organization: Synthesis and Solid State Pharmaceutical Centre (SSPC), School of Chemical and Bioprocess Engineering – sequence: 2 givenname: Philip orcidid: 0000-0001-8576-7857 surname: Donnellan fullname: Donnellan, Philip organization: Synthesis and Solid State Pharmaceutical Centre (SSPC), School of Chemical and Bioprocess Engineering – sequence: 3 givenname: Brian surname: Glennon fullname: Glennon, Brian organization: APC Ltd – sequence: 4 givenname: Barbara surname: Wood fullname: Wood, Barbara email: Barbara.wood@approcess.com organization: APC Ltd – sequence: 5 givenname: Roderick C orcidid: 0000-0002-2884-4884 surname: Jones fullname: Jones, Roderick C email: Roderick.jones@ucd.ie organization: Synthesis and Solid State Pharmaceutical Centre (SSPC), School of Chemical and Bioprocess Engineering |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35559147$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1u1TAQhSNUREvpnhXKskik2E7iOBskFH6lQhEX1pbjTBJXjp3aTsVl1VdAPADv1ifBcG-rCxIsLI883zljzbmf7BlrIEkeYnSCEcFPhfR2gkGcYIkqQtid5IAUFcpwXuR7O_V-cuT9OUIIU0YYofeS_bwsyxoX1UHy4wV4NZhUmC49m4Oa1FcRlDWp7dMwQrpSZtCQrYIYIG2sCcosdvHpO_UFunS1-BmMj_z11ffN0wdnu0WG9CNM9lLotHFrH4TWO77k-upbM2rrbCzex3NcZBOEca3nEcxaP56djbZiUh08SO72Qns42t6HyedXLz81b7LTs9dvm-enmchpHjJoCwaso4QUkrWAUUfrsqQScNV1VZszQijp85LhivYtSNIjTLqKibJmNenr_DB5tvGdl3aCToIJTmg-OzUJt-ZWKP5nx6iRD_aS14ixuiDR4Hhr4OzFAj7wSXkJWgsDcWGcUFowlNcljeij3Vm3Q25SiQDaANJZ7x30twhG_Ff2_CZ7vs0-SuhfEqnC743H3yr9P-GTjTB2-LldnIlr_jf-E0uezMg |
CitedBy_id | crossref_primary_10_3390_cryst14121021 crossref_primary_10_1016_j_cherd_2023_01_020 |
Cites_doi | 10.1002/aic.690230415 10.1002/ejoc.201700871 10.1021/acs.oprd.5b00325 10.1021/acs.oprd.5b00001 10.1021/cg401904a 10.1016/j.ces.2015.02.014 10.1002/anie.201409318 10.1016/j.cep.2015.01.001 10.1002/ceat.201700427 10.1021/acs.jced.7b00288 10.1021/op900237x 10.1021/op200347k 10.1021/acs.cgd.5b01290 10.1039/c0cc05060a 10.1016/j.jiec.2017.06.009 10.1016/J.ENG.2017.03.023 10.1021/acs.oprd.8b00440 10.1039/c0ob00368a 10.1021/acs.oprd.5b00139 10.1016/j.ces.2013.09.006 10.1208/s12249-017-0819-9 10.1002/ejoc.201900184 10.1002/ejoc.201900494 10.1039/C5CS00902B 10.1016/j.tet.2010.04.057 10.1021/acs.oprd.8b00319 10.1002/aic.16466 10.1107/S2056989018013889 10.1007/s12247-015-9215-8 10.1021/cg101556s 10.1039/c0ob00805b 10.1016/j.tetasy.2010.05.004 10.1038/nchem.1753 |
ContentType | Journal Article |
Copyright | 2022 The Authors. Published by American Chemical Society 2022 The Authors. Published by American Chemical Society. 2022 The Authors. Published by American Chemical Society 2022 The Authors |
Copyright_xml | – notice: 2022 The Authors. Published by American Chemical Society – notice: 2022 The Authors. Published by American Chemical Society. – notice: 2022 The Authors. Published by American Chemical Society 2022 The Authors |
DBID | N~. AAYXX CITATION NPM 7X8 5PM |
DOI | 10.1021/acsomega.1c07228 |
DatabaseName | American Chemical Society (ACS) Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: N~. name: American Chemical Society (ACS) Open Access url: https://pubs.acs.org sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 2470-1343 |
EndPage | 13686 |
ExternalDocumentID | PMC9088942 35559147 10_1021_acsomega_1c07228 c161439138 |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; grantid: NA – fundername: ; grantid: 12/RC/2275 |
GroupedDBID | 53G ABFRP ABUCX ACS ADACO ADBBV AFEFF ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV EBS GROUPED_DOAJ HYE N~. OK1 RPM VF5 AAFWJ AAHBH AAYXX ABBLG ADUCK AFPKN CITATION M~E NPM 7X8 5PM |
ID | FETCH-LOGICAL-a363t-eb48e8d6224c8be10d69556ce17dd7b382262f358176fbec2f012d78a59892f93 |
IEDL.DBID | ACS |
ISSN | 2470-1343 |
IngestDate | Thu Aug 21 18:12:14 EDT 2025 Fri Jul 11 10:07:33 EDT 2025 Mon Jul 21 05:46:19 EDT 2025 Tue Jul 01 01:06:15 EDT 2025 Thu Apr 24 23:03:36 EDT 2025 Thu Apr 28 04:09:17 EDT 2022 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 16 |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 2022 The Authors. Published by American Chemical Society. Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a363t-eb48e8d6224c8be10d69556ce17dd7b382262f358176fbec2f012d78a59892f93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8576-7857 0000-0002-2884-4884 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=http://dx.doi.org/10.1021/acsomega.1c07228 |
PMID | 35559147 |
PQID | 2664803956 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9088942 proquest_miscellaneous_2664803956 pubmed_primary_35559147 crossref_primary_10_1021_acsomega_1c07228 crossref_citationtrail_10_1021_acsomega_1c07228 acs_journals_10_1021_acsomega_1c07228 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-04-26 |
PublicationDateYYYYMMDD | 2022-04-26 |
PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-26 day: 26 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | ACS omega |
PublicationTitleAlternate | ACS Omega |
PublicationYear | 2022 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | ref9/cit9 ref3/cit3 ref27/cit27 ref18/cit18 ref11/cit11 ref25/cit25 ref16/cit16 ref29/cit29 Gutmann B. (ref6/cit6) 2015; 33 ref32/cit32 ref23/cit23 ref14/cit14 ref8/cit8 ref5/cit5 ref31/cit31 ref2/cit2 ref34/cit34 ref28/cit28 ref20/cit20 ref17/cit17 ref10/cit10 ref26/cit26 ref35/cit35 ref19/cit19 ref21/cit21 ref12/cit12 ref15/cit15 ref22/cit22 ref13/cit13 ref33/cit33 ref4/cit4 ref30/cit30 ref1/cit1 ref24/cit24 ref7/cit7 |
References_xml | – ident: ref35/cit35 doi: 10.1002/aic.690230415 – ident: ref10/cit10 doi: 10.1002/ejoc.201700871 – volume: 33 start-page: 18 issue: 3 year: 2015 ident: ref6/cit6 publication-title: Chim. Oggi – ident: ref5/cit5 doi: 10.1021/acs.oprd.5b00325 – ident: ref12/cit12 doi: 10.1021/acs.oprd.5b00001 – ident: ref14/cit14 doi: 10.1021/cg401904a – ident: ref16/cit16 doi: 10.1016/j.ces.2015.02.014 – ident: ref3/cit3 doi: 10.1002/anie.201409318 – ident: ref31/cit31 doi: 10.1016/j.cep.2015.01.001 – ident: ref17/cit17 doi: 10.1002/ceat.201700427 – ident: ref20/cit20 doi: 10.1021/acs.jced.7b00288 – ident: ref27/cit27 doi: 10.1021/op900237x – ident: ref1/cit1 doi: 10.1021/op200347k – ident: ref30/cit30 doi: 10.1021/acs.cgd.5b01290 – ident: ref11/cit11 doi: 10.1039/c0cc05060a – ident: ref34/cit34 doi: 10.1016/j.jiec.2017.06.009 – ident: ref26/cit26 doi: 10.1016/J.ENG.2017.03.023 – ident: ref2/cit2 doi: 10.1021/acs.oprd.8b00440 – ident: ref23/cit23 doi: 10.1039/c0ob00368a – ident: ref15/cit15 doi: 10.1021/acs.oprd.5b00139 – ident: ref28/cit28 doi: 10.1016/j.ces.2013.09.006 – ident: ref33/cit33 doi: 10.1208/s12249-017-0819-9 – ident: ref8/cit8 doi: 10.1002/ejoc.201900184 – ident: ref22/cit22 doi: 10.1002/ejoc.201900494 – ident: ref9/cit9 doi: 10.1039/C5CS00902B – ident: ref21/cit21 doi: 10.1016/j.tet.2010.04.057 – ident: ref13/cit13 doi: 10.1021/acs.oprd.8b00319 – ident: ref29/cit29 – ident: ref18/cit18 doi: 10.1002/aic.16466 – ident: ref19/cit19 doi: 10.1107/S2056989018013889 – ident: ref4/cit4 doi: 10.1007/s12247-015-9215-8 – ident: ref32/cit32 doi: 10.1021/cg101556s – ident: ref24/cit24 doi: 10.1039/c0ob00805b – ident: ref25/cit25 doi: 10.1016/j.tetasy.2010.05.004 – ident: ref7/cit7 doi: 10.1038/nchem.1753 |
SSID | ssj0001682826 |
Score | 2.1986697 |
Snippet | A continuously operated single-stage mixed suspension–mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of... A continuously operated single-stage mixed suspension-mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of... A continuously operated single-stage mixed suspension–mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of... |
SourceID | pubmedcentral proquest pubmed crossref acs |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 13676 |
Title | Design and Optimization of the Single-Stage Continuous Mixed Suspension–Mixed Product Removal Crystallization of 2‑Chloro‑N‑(4-methylphenyl)propenamide |
URI | http://dx.doi.org/10.1021/acsomega.1c07228 https://www.ncbi.nlm.nih.gov/pubmed/35559147 https://www.proquest.com/docview/2664803956 https://pubmed.ncbi.nlm.nih.gov/PMC9088942 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVABC databaseName: American Chemical Society (ACS) Open Access customDbUrl: eissn: 2470-1343 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001682826 issn: 2470-1343 databaseCode: N~. dateStart: 20160731 isFulltext: true titleUrlDefault: https://pubs.acs.org providerName: American Chemical Society – providerCode: PRVABC databaseName: American Chemical Society Journals customDbUrl: eissn: 2470-1343 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001682826 issn: 2470-1343 databaseCode: ACS dateStart: 20160731 isFulltext: true titleUrlDefault: https://pubs.acs.org/action/showPublications?display=journals providerName: American Chemical Society – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2470-1343 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001682826 issn: 2470-1343 databaseCode: DOA dateStart: 20160101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2470-1343 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001682826 issn: 2470-1343 databaseCode: M~E dateStart: 20160101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2470-1343 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001682826 issn: 2470-1343 databaseCode: RPM dateStart: 20160101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3datswFBZbd7Hd7H9d9lM02GC9UCrJsixfFq-lDJKNZYXeGVuS2zDHDnEMyy5KX2HsAfZufZId2U7atKP0wsLIkkDSkc8nnaPvIPSeaam0FJZoKSkRGSSKUUpCmVKmA8ho7nEPhvLgUHw-8o8uaHKuWvA520l0VU7scdJnmgacq7voHpeKuY3WbjS6OE-RsHdooqtxEVDCPOF1Vsn_NeJ0ka7WddE1gHnVT_KS4tl_1EYwqhq-Qudv8qNfz9O-_nWdzfEWfXqMHnb4E--2AvME3bHFU3Q_WoZ9e4b-fmp8OnBSGPwF_ieT7qImLjMMYBGPQNfllgBIPbbYcVuNi7qsKzwY_7QGj-pq6lziy-L87E-b9bXllMXf7KQEscbRbAGINM8vtcvPz35HJ3k5K-FlCM9HQVxo60XuPNAW-fbUmQyKZDI29jk63N_7Hh2QLooDSTzpzYlNhbLKSMAKWqWWUSND35fassCYIPUAoUieORq2QGYgUTwDnWkClfihCnkWei_QRlEW9iXCCaAXk1lDU-tgnAlpqH3KjPGyTHo66KEPMLJxtwqruDGwcxYvhzvuhruHdpbzHuuOCt1F5MhvqLG9qjFtaUBuKPtuKUoxzJ0zwCSFhZmIAQwJRT3YkvbQZitaq9YA9_khE9CHYE3oVgUcD_j6l2J80vCBN65qgr-6Ze9fowfc3eGggnD5Bm3MZ7V9C8hqnm41S2qrOZeAdHC6B-nwtP8P5SkqIw |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLbGeBgv3C_laiSQ2IM723Gc5BEFpgJrQesm7S1KbGerSJOqaSTK0_4C4gfw3_ZLOM6lWwea4CFR5NiWL8c5n3OOv4PQK6akr6QwRElJiUjh5jNKSSATypQHCfU57uFIDg7FxyP3aAOx7iwMNKKEmsraiH_OLsB2IK2YmuO4zxT1OPevoes1EYpFQ-H4_LeKhC1EHWSNC48S5ginNU7-rRKrklS5rpL-wJmX3SUv6J_dW2h_1fLa7eRrv1okffX9Eqnjf3XtNrrZolH8thGfO2jD5HfRVtgFgbuHfr2rPTxwnGv8Gb4u0_bYJi5SDNARj0HzZYYAZD022DJdTfKqqEo8nHwzGo-rcmYd5Iv87PRnk_SlYZjF-2ZagJDjcL4EfJplF-rlZ6c_wpOsmBfwMILrjSA20PUys_5oy2x7Zg0IeTydaHMfHe6-PwgHpI3pQGJHOgtiEuEbX0tADspPDKNaBq4rlWGe1l7iAF6RPLWkbJ5MQb54ChpUe37sBn7A08B5gDbzIjePEI4By-jUaJoYC-p0QAPlUqa1k6bSUV4PvYaRjdo1WUa1uZ2zqBvuqB3uHtrppj9SLTG6jc-RXVFie1Vi1pCCXJH3ZSdREcydNcfEuYGZiAAaCZ86sEHtoYeNhK1qAxToBkxAH7w12VtlsKzg62_yyUnNDl47rgn--B97_wJtDQ6Ge9Heh9GnJ-gGt6c7qCBcPkWbi3llngHmWiTP61X2G9j7L00 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9RAFB5qC-pLab2uVh1BwT5MO7dMkkfZutRL12It9C0kc2kXssnS7EL3RfoXxB_gf-sv8Uwua1el-JAQJjOHDOdMzjdzbgi9YlpFWklLtFKUSAe3iFFKYpVRpkNoqOO4D4Zq_1h-OAlOVlDQxcLAR1RAqaqN-H5VT4xrMwywXWgvx_Y03WGahpxHt9Aa4BHhxXv4bef30YqCbURdaI3LkBImpGgNlP8i4tWSrpbV0l9Y80-XyWs6aLCB1lvwiN823N5EK7a4h-70u5pt99HPvdohA6eFwZ_hZzBuoyxx6TAgPXwEiiq3BBDmqcU-MdWomMHWHx-MLqzBR7Nq4v3Zy-Lq8kfTdNgkhMVf7LgEmcT98znAyTy_RpdfXX7vn8G2v4SHIVxvJPF1qee5dx-b59sTf97v694b-wAdD9597e-TtgQDSYUSU2IzGdnIKFD0Ososo0bFQaC0ZaExYSYAXijufA61UDkQB-5A4ZkwSoM4irmLxUO0WpSFfYxwCtDDOGtoZj0GMzGNdUCZMcI5JXTYQ6-BD0m7hKqkto5zlnT8Slp-9dBux6lEt3nMfTmN_IYR24sRkyaHxw19X3bMT4B33nqSFhY4kQCSkREVsJ_soUeNMCyoAWgLYiZhDuGSmCw6-CTey2-K0VmdzLv2M5P8yX_O_gW6fbg3SD69H358iu5yH4tBJeFqC61Oz2f2GSCkafa8Xg-_AJPWFHk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Design+and+Optimization+of+the+Single-Stage+Continuous+Mixed+Suspension%E2%80%93Mixed+Product+Removal+Crystallization+of+2%E2%80%91Chloro%E2%80%91N%E2%80%91%284-methylphenyl%29propenamide&rft.jtitle=ACS+omega&rft.au=Pascual%2C+Gladys+Kate&rft.au=Donnellan%2C+Philip&rft.au=Glennon%2C+Brian&rft.au=Wood%2C+Barbara&rft.date=2022-04-26&rft.pub=American+Chemical+Society&rft.issn=2470-1343&rft.eissn=2470-1343&rft.volume=7&rft.issue=16&rft.spage=13676&rft.epage=13686&rft_id=info:doi/10.1021%2Facsomega.1c07228&rft.externalDocID=c161439138 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2470-1343&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2470-1343&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2470-1343&client=summon |